Kechichian E - Search Results

1

Kechichian E, Dupin N, Wetter DA, Ortonne N, Agbo-Godeau S, Chosidow O. Kechichian E, et al. EClinicalMedicine. 2024 Nov 9;77:102909. doi: 10.1016/j.eclinm.2024.102909. eCollection 2024 Nov. EClinicalMedicine. 2024. PMID: 39583748 Free PMC article. Review.

2

Topical imiquimod adverse event: Beyond the local skin reaction-A case report.

Lagacé-Thomassin F, Nateghi A, Kechichian E, Veilleux M. Lagacé-Thomassin F, et al. Among authors: kechichian e. SAGE Open Med Case Rep. 2024 Aug 19;12:2050313X241274916. doi: 10.1177/2050313X241274916. eCollection 2024. SAGE Open Med Case Rep. 2024. PMID: 39165296 Free PMC article.

3

Triggers, clinical manifestations and assessment of paediatric fixed drug eruptions: A systematic review of the literature.

Mathieu A, de Grandmont M, Fernandes CL, Kechichian E. Mathieu A, et al. Among authors: kechichian e. Contact Dermatitis. 2024 Apr;90(4):343-349. doi: 10.1111/cod.14500. Epub 2024 Jan 17. Contact Dermatitis. 2024. PMID: 38234071 Review.

4

Dermatological manifestations associated with COVID-19 and COVID-19 vaccination: results from the Lebanese COVID registry.

Chrabieh R, Haddad I, Salameh P, Kurban M, Kechichian E, Habre M, Ayoub N, Torbey G, El Sayed F, Maamari M, Tannous Z, Farra A; Lebanese COVID Rash Consortium; El Khoury J. Chrabieh R, et al. Among authors: kechichian e. Int J Dermatol. 2023 Oct;62(10):1248-1256. doi: 10.1111/ijd.16815. Epub 2023 Aug 28. Int J Dermatol. 2023. PMID: 37638543

5

Combination Topical Tranexamic Acid and Vitamin C for the Treatment of Refractory Melasma.

Kaikati J, El Bcherawi N, Khater JA, Dib SM, Kechichian E, Helou J. Kaikati J, et al. Among authors: kechichian e. J Clin Aesthet Dermatol. 2023 Jul;16(7):63-65. J Clin Aesthet Dermatol. 2023. PMID: 37560507 Free PMC article.

6

Botulinum Toxins and Zinc: From Theory to Practice-A Systematic Review.

Mallat F, Kaikati J, Kechichian E. Mallat F, et al. Among authors: kechichian e. Clin Neuropharmacol. 2023 Jun 20. doi: 10.1097/WNF.0000000000000557. Online ahead of print. Clin Neuropharmacol. 2023. PMID: 37335837

7

Has the core outcome (domain) set for vitiligo been implemented? An updated systematic review on outcomes and outcome measures in vitiligo randomized clinical trials.

Eleftheriadou V, Bergqvist C, Kechichian E, Shourick J, Ju HJ, van Geel N, Bae JM, Ezzedine K. Eleftheriadou V, et al. Among authors: kechichian e. Br J Dermatol. 2023 Feb 10;188(2):247-258. doi: 10.1093/bjd/ljac074. Br J Dermatol. 2023. PMID: 36763863

8

Prevalence of adverse events varies with the different oral isotretinoin brands in acne treatment: a retrospective observational study.

Soutou B, Sleiman J, Tomb R, Kechichian E, Helou J. Soutou B, et al. Among authors: kechichian e. Arch Dermatol Res. 2023 Aug;315(6):1533-1539. doi: 10.1007/s00403-023-02532-6. Epub 2023 Jan 19. Arch Dermatol Res. 2023. PMID: 36656385

9

Cimetidine and racecadotril: Unusual culprit drugs of a severe cutaneous adverse reaction.

Kechichian E, Weill A, Ingen-Housz-Oro S, Assier H. Kechichian E, et al. Contact Dermatitis. 2022 Nov;87(5):451-452. doi: 10.1111/cod.14176. Epub 2022 Jul 1. Contact Dermatitis. 2022. PMID: 35715974 No abstract available.

10

Psoriasis features associated with infertility and adverse pregnancy outcomes.

Soutou B, El Hachem G, Helou J, Stéphan F, Kechichian E, Zeinaty P, Tomb R. Soutou B, et al. Among authors: kechichian e. Ann Dermatol Venereol. 2022 Sep;149(3):200-201. doi: 10.1016/j.annder.2022.01.004. Epub 2022 Feb 17. Ann Dermatol Venereol. 2022. PMID: 35184904 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters